Complete Filing Data
GHST World Inc. reported Stockholders Equity of -$121.5 thousand for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean GHST World Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$182.8K | -$511.3K | -$116.6K | -$4.0M | -$151.4K | |
| Operating Expenses | $242.5K | $551.9K | $119.4K | $319.4K | $151.4K | $37.7K |
| General And Administrative Expense | $230.2K | $540.1K | $114.6K | $165.2K | $151.4K | $37.7K |
| Nonoperating Income Expense | -$780.00 | -$317.00 | -$227.00 | -$3.7M | ||
| Revenues | $60.5K | $40.9K | $3.1K | |||
| Research And Development Expense | $4.8K | |||||
| Deferred Revenue Current | $37.1K | $23.8K | ||||
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | |||
| Interest Expense | $150.00 | |||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$182.8K | -$511.3K | ||||
| Income Tax Expense Benefit | $0.00 | $0.00 | ||||
| Impairment Of Long Lived Assets Held For Use | $154.2K | |||||
| Comprehensive Income Net Of Tax | ||||||
| Other Nonoperating Income Expense | -$780.00 | -$317.00 | ||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$15.9K | -$34.2K | -$31.5K | -$45.7K | -$12.7K | -$27.9K | -$380.7K | -$56.1K | -$21.0K | -$23.6K | -$48.9K | -$23.9K | -$33.7K | -$59.0K | -$46.8K | -$36.7K | -$10.1K | -$6.8K | |
| Operating Expenses | $26.3K | $38.5K | $36.3K | $50.6K | $58.4K | $28.6K | $397.3K | $78.8K | $21.0K | $23.4K | $48.9K | $23.9K | $31.9K | $59.0K | $46.8K | $36.7K | $10.1K | $6.8K | |
| General And Administrative Expense | $23.7K | $35.0K | $36.3K | $48.3K | $51.8K | $28.6K | $72.8K | $78.8K | $21.0K | $19.2K | $48.9K | $23.9K | $31.9K | $59.0K | $46.8K | $36.7K | $10.1K | $6.8K | |
| Nonoperating Income Expense | $0.00 | $820.00 | $0.00 | $0.00 | $0.00 | $258.00 | $761.00 | -$1.1K | $0.00 | -$227.00 | -$1.9K | ||||||||
| Revenues | $10.4K | $3.5K | $4.8K | $4.9K | $45.7K | $431.00 | $15.9K | $23.8K | $0.00 | ||||||||||
| Research And Development Expense | $0.00 | $0.00 | $0.00 | $324.5K | $0.00 | ||||||||||||||
| Deferred Revenue Current | $34.1K | $44.5K | $37.5K | $0.00 | $8.3K | $0.00 | $17.4K | $17.4K | $17.4K | ||||||||||
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Interest Expense | $150.00 | ||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$15.9K | -$34.2K | -$45.7K | -$12.7K | |||||||||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | |||||||||||||||||
| Impairment Of Long Lived Assets Held For Use | $115.0K | ||||||||||||||||||
| Comprehensive Income Net Of Tax | -$20.9K | -$33.7K | |||||||||||||||||
| Other Nonoperating Income Expense | |||||||||||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$227.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$121.5K | -$101.0K | -$87.0K | -$109.1K | -$71.4K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $39.5K | $206.00 | $7.4K | $292.00 | |||
| Retained Earnings Accumulated Deficit | -$13.9M | -$13.4M | -$13.3M | -$9.3M | -$9.1M | ||
| Common Stock Payable | $9.6K | $9.6K | $9.6K | $217.8K | $240.7K | ||
| Liabilities Current | $330.3K | $161.0K | $101.2K | $248.6K | $256.1K | ||
| Common Stock Value | $130.2K | $125.7K | $124.4K | $5.2K | $397.9K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$15.8K | -$21.2K | $39.3K | -$7.1K | $7.1K | -$1.8K | |
| Assets Current | $22.1K | $39.5K | $206.00 | $7.4K | $292.00 | ||
| Assets | $22.1K | $39.5K | $206.00 | $161.5K | $147.1K | ||
| Accounts Payable And Accrued Liabilities Current | $13.8K | $1.1K | $1.7K | $14.5K | $7.1K | ||
| Liabilities And Stockholders Equity | $22.1K | $39.5K | $206.00 | $161.5K | $147.1K | ||
| Issuance Of Common Stock In Exchange For Debt | $225.3K | $24.9K | |||||
| Other Assets Noncurrent | $115.0K | $115.0K | |||||
| Accounts Receivable Net Current | $0.00 | $3.7K | $0.00 | ||||
| Issuance Of Shares In Exchange Of Debt | 3.9M | 24.9K | |||||
| Debt Securities Gain Loss | -$1.7K | ||||||
| Shareholders Equity | |||||||
| Stockholder Equity |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$541.3K | -$525.3K | -$491.1K | -$398.2K | -$366.7K | -$321.0K | -$308.3K | -$261.7K | -$233.8K | -$177.6K | -$119.5K | -$100.5K | -$106.2K | $52.1K | -$59.0K | -$129.3K | -$29.1K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.1K | $1.8K | $2.5K | $144.00 | $240.00 | $2.2K | $18.3K | $77.00 | $1.1K | $7.4K | $538.00 | $686.00 | $882.00 | $362.00 | $1.0K | $4.1K | $55.6K | ||
| Retained Earnings Accumulated Deficit | -$14.1M | -$14.1M | -$14.1M | -$14.0M | -$13.9M | -$13.9M | -$13.8M | -$13.8M | -$13.4M | -$13.3M | -$13.3M | -$13.3M | -$9.4M | -$9.4M | -$9.3M | -$9.2M | |||
| Common Stock Payable | $9.6K | $9.6K | $9.6K | $9.6K | $9.6K | $9.6K | $9.6K | $9.6K | $9.6K | $9.6K | $9.6K | $9.6K | $9.6K | $138.8K | $233.1K | $123.2K | |||
| Liabilities Current | $542.3K | $527.2K | $493.6K | $400.0K | $375.3K | $323.2K | $268.1K | $241.2K | $195.6K | $105.7K | $86.6K | $92.6K | $102.4K | $214.1K | $287.5K | $241.5K | |||
| Common Stock Value | $130.2K | $130.2K | $130.2K | $130.2K | $130.2K | $130.2K | $130.2K | $130.2K | $125.7K | $125.3K | $125.2K | $124.9K | $124.0K | $54.1K | $5.3K | $523.9K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$670.00 | -$16.1K | -$32.1K | $676.00 | -$3.3K | $157.00 | |||||||||||||
| Assets Current | $1.1K | $1.8K | $2.5K | $1.8K | $8.6K | $2.2K | $6.4K | $7.4K | $18.0K | $539.00 | $461.00 | $882.00 | $362.00 | $1.0K | $4.1K | $55.6K | |||
| Assets | $1.1K | $1.8K | $2.5K | $1.8K | $8.6K | $2.2K | $6.4K | $7.4K | $18.0K | $40.9K | $42.4K | $40.1K | $154.5K | $155.2K | $158.3K | $212.4K | |||
| Accounts Payable And Accrued Liabilities Current | $8.8K | $21.7K | $28.8K | $2.9K | $837.00 | $14.7K | $26.3K | $24.2K | $31.0K | $2.8K | $3.0K | $12.3K | $15.7K | $12.5K | $16.4K | $10.0K | |||
| Liabilities And Stockholders Equity | $1.1K | $1.8K | $2.5K | $1.8K | $8.6K | $2.2K | $6.4K | $7.4K | $18.0K | $40.9K | $42.4K | $40.1K | $154.5K | $155.2K | $158.3K | $212.4K | |||
| Issuance Of Common Stock In Exchange For Debt | $129.2K | $16.7K | $24.9K | ||||||||||||||||
| Other Assets Noncurrent | $115.0K | $115.0K | $115.0K | $115.0K | $115.0K | ||||||||||||||
| Accounts Receivable Net Current | $1.7K | $8.3K | $0.00 | $6.3K | $6.3K | $6.3K | |||||||||||||
| Issuance Of Shares In Exchange Of Debt | 79.3K | 16.7K | |||||||||||||||||
| Debt Securities Gain Loss | -$1.7K | ||||||||||||||||||
| Shareholders Equity | -$64.8K | -$117.1K | |||||||||||||||||
| Stockholder Equity | $52.1K | -$59.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$163.7K | -$164.6K | -$93.3K | -$163.0K | -$143.9K | -$36.6K |
| Net Cash Provided By Used In Financing Activities | $147.9K | $143.4K | $132.6K | $155.9K | $158.4K | $53.9K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $15.0K | $12.7K | -$574.00 | -$12.8K | $7.4K | $752.00 |
| Proceeds From Issuance Of Common Stock | $0.00 | $96.1K | $81.3K | $148.5K | ||
| Proceeds From Repayments Of Related Party Debt | $147.9K | $143.4K | $36.5K | |||
| Increase Decrease In Accounts Receivable | -$3.7K | $3.7K | $0.00 | -$329.00 | ||
| Increase Decrease In Deferred Revenue | $408.00 | $13.3K | $23.8K | |||
| Proceeds From Related Party Debt | $36.5K | $59.2K | $7.9K | $24.9K | ||
| Share Based Compensation | $0.00 | $324.5K | $0.00 | |||
| Payments To Acquire Intangible Assets | $0.00 | $7.4K | $19.1K | |||
| Net Cash Provided By Used In Investing Activities | -$7.4K | -$19.1K | ||||
| Proceeds From Repayment Of Loans To Purchase Common Stock | $15.3K | $2.0K | ||||
| Increase Decrease In Due To Related Parties | ||||||
| Proceeds From Issuance Or Sale Of Equity | $148.5K | |||||
| Depreciation Depletion And Amortization | ||||||
| Increase Decrease In Prepaid Expense |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q3 2024 | Q3 2023 | Q4 2022 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$34.4K | -$45.2K | -$43.3K | -$38.3K | -$57.1K | -$13.9K | |
| Net Cash Provided By Used In Financing Activities | $33.7K | $29.0K | $11.2K | $38.9K | $53.8K | $15.7K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$7.1K | $893.00 | $29.9K | $10.6K | $1.9K | -$3.8K | |
| Proceeds From Issuance Of Common Stock | $43.6K | ||||||
| Proceeds From Repayments Of Related Party Debt | $33.7K | $29.0K | $11.2K | -$4.7K | |||
| Increase Decrease In Accounts Receivable | $0.00 | -$3.7K | $6.3K | ||||
| Increase Decrease In Deferred Revenue | $7.0K | -$37.1K | -$6.5K | ||||
| Proceeds From Related Party Debt | $21.8K | $15.7K | |||||
| Share Based Compensation | |||||||
| Payments To Acquire Intangible Assets | $0.00 | $1.6K | |||||
| Net Cash Provided By Used In Investing Activities | -$1.6K | ||||||
| Proceeds From Repayment Of Loans To Purchase Common Stock | $32.1K | ||||||
| Increase Decrease In Due To Related Parties | -$4.7K | $21.8K | |||||
| Proceeds From Issuance Or Sale Of Equity | $32.1K | ||||||
| Depreciation Depletion And Amortization | $1.4K | ||||||
| Increase Decrease In Prepaid Expense | $0.00 | $4.3K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | $0.00 | -$0.07 | -$0.03 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 130.2M | 129.1M | 125.0M | 54.0M | 4.8M | |
| Weighted Average Number Of Diluted Shares Outstanding | 130.2M | 129.1M | 125.0M | 54.0M | 4.8M | |
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 | $-0.07 | $-0.03 | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 310.0M | 700.0M | |
| Common Stock Shares Issued | 130.2M | 125.7M | 124.4M | 5.2M | 397.9M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 130.2M | 397.9M | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 476.1M | 397.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 130.2M | 130.2M | 130.2M | 130.2M | 130.2M | 130.2M | 130.1M | 125.7M | 25.2M | 125.1M | 125.0M | 82.4M | 5.9M | 5.2M | 5.1M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 130.2M | 130.2M | 130.2M | 130.2M | 130.2M | 130.2M | 130.1M | 125.7M | 25.2M | 125.1M | 125.0M | 82.4M | 5.9M | 5.2M | 5.1M | ||||||
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.01 | $-0.01 | $-0.01 | ||||||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 700.0M | ||||||
| Common Stock Shares Issued | 130.2M | 130.2M | 130.2M | 130.2M | 130.2M | 130.2M | 130.2M | 130.2M | 125.7M | 125.3M | 125.2M | 124.9M | 124.0M | 54.1M | 523.9M | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Common Stock Shares Outstanding | 130.2M | 130.2M | 130.2M | 130.2M | 130.2M | 125.3M | 125.2M | 124.9M | 124.4M | 54.1M | 5.2M | 523.9M | |||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 5.9M | 5.2M | 514.6M | 4.3M | 4.2M | 397.9M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Additional Paid In Capital | $13.4M | $13.1M | $13.0M | $9.2M | $8.6M | |
| Stock Issued During Period Value New Issues | $96.1K | $81.3K | ||||
| Due To Related Party Current | $269.9K | $126.5K | $90.0K | |||
| Other Income | -$317.00 | -$227.00 | ||||
| Patent Development Costs | $12.4K | $11.8K | $4.8K | |||
| Interest Paid Net | $0.00 | $0.00 | $0.00 | |||
| Due To Related Parties Current | $16.2K | $8.3K | ||||
| Finite Lived Patents Gross | $39.2K | $31.8K | ||||
| Other Expenses | ||||||
| Finite Lived Patents Net | ||||||
| Stock Issued During Period Value Issued For Services | $324.5K | $96.1K | ||||
| Fair Value Option Changes In Fair Value Gain Loss1 | -$1.7K | |||||
| Depreciation And Amortization | ||||||
| Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax | -$227.00 | $668.00 | ||||
| Stock Issued During Period Shares New Issues |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $13.4M | $13.4M | $13.4M | $13.4M | $13.4M | $13.4M | $13.4M | $13.4M | $13.1M | $9.4M | $9.4M | $9.4M | $9.3M | $9.2M | $9.2M | $8.7M | |
| Stock Issued During Period Value New Issues | $324.5K | $2.0K | $29.3K | $43.6K | $5.8K | $24.7K | |||||||||||
| Due To Related Party Current | $489.8K | $451.5K | $417.8K | $387.6K | $356.5K | $298.9K | $214.9K | $190.1K | $137.7K | $93.4K | |||||||
| Other Income | $0.00 | $846.00 | $0.00 | $0.00 | $0.00 | $258.00 | $761.00 | -$1.1K | $0.00 | -$227.00 | |||||||
| Patent Development Costs | $2.6K | $3.5K | $0.00 | $2.3K | $6.7K | $0.00 | $0.00 | $4.2K | |||||||||
| Interest Paid Net | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Due To Related Parties Current | $74.0K | $70.8K | $75.4K | $77.1K | $62.9K | $38.0K | $13.7K | ||||||||||
| Finite Lived Patents Gross | $39.2K | $39.2K | $39.2K | $39.2K | $39.2K | $41.8K | |||||||||||
| Other Expenses | $0.00 | $26.00 | $0.00 | $0.00 | |||||||||||||
| Finite Lived Patents Net | $40.4K | $42.0K | $39.2K | ||||||||||||||
| Stock Issued During Period Value Issued For Services | $324.5K | ||||||||||||||||
| Fair Value Option Changes In Fair Value Gain Loss1 | -$1.7K | ||||||||||||||||
| Depreciation And Amortization | $1.6K | ||||||||||||||||
| Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax | -$1.1K | ||||||||||||||||
| Stock Issued During Period Shares New Issues | 452.0K |
Most recent annual filing with the SEC: October 14, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.